SR-17018

SR-17018 Overview

SR-17018 is a structurally distinct, G-protein-biased mu-opioid receptor (MOR) agonist that has garnered significant attention in the field of emerging opioid research. As part of the orphine chemical class, SR-17018 was engineered to selectively activate G-protein signaling pathways while minimizing beta-arrestin-2 recruitment — a mechanistic profile hypothesized to dissociate analgesic efficacy from adverse opioid effects such as respiratory depression, tolerance development, and constipation. This biased agonism paradigm has made SR-17018 one of the most studied reference compounds in contemporary opioid pharmacology.

For laboratories investigating the therapeutic potential of next-generation opioids, the ability to buy SR-17018 from a trusted, GMP-compliant supplier is essential. Cayman Chemical Company offers SR-17018 for sale with verified purity, full analytical documentation, and fast fulfillment — giving researchers the resources they need to push the boundaries of opioid receptor science. Whether your focus is on structure-activity relationships (SAR), receptor binding affinity studies, or in vivo pharmacodynamic profiling, SR-17018 is an indispensable reference standard and research tool.

SR-17018 belongs to a broader family of novel opioid compounds under active investigation. Researchers working with related orphine-class molecules such as Cychlorphine and Brorphine will find SR-17018 a highly complementary addition to their compound library, enabling comparative receptor pharmacology studies that illuminate the structural determinants of biased signaling.

Key Features and Benefits of SR-17018

• G-Protein Biased Agonism: SR-17018 preferentially activates G-protein-mediated intracellular signaling over beta-arrestin-2 recruitment at the mu-opioid receptor, providing a clean pharmacological tool for bias research.
• High Receptor Selectivity: Demonstrated selectivity for the mu-opioid receptor (MOR) over delta and kappa opioid receptor subtypes, reducing off-target confounds in experimental models.
• Superior Purity: Each lot of SR-17018 is manufactured to high analytical standards, with purity confirmed by HPLC, NMR, and mass spectrometry — ensuring reproducible, publication-quality results.
• Comprehensive Documentation: Full certificate of analysis (CoA), safety data sheet (SDS), and structural characterization data accompany every order.
• Versatile Research Applications: Suitable for in vitro receptor binding assays, cAMP inhibition studies, beta-arrestin recruitment assays (BRET/HTRF), and in vivo preclinical analgesic models.
• Competitive Pricing: Order SR-17018 online from Cayman Chemical Company and access best-in-class pricing without compromising on quality or compliance.
• Stable Formulation: Provided as a solid or DMSO solution depending on lot specifications, with clearly defined storage recommendations for maximum shelf stability.
• Complementary Compound Portfolio: Pair SR-17018 with related orphine-class compounds such as Spirochlorphine for comprehensive comparative opioid receptor studies.

SR-17018 Specifications

Frequently Asked Questions About SR-17018

What makes SR-17018 different from traditional mu-opioid receptor agonists in research settings?

SR-17018 is distinguished from classical mu-opioid agonists such as morphine or DAMGO by its highly G-protein-biased pharmacological profile. While traditional MOR agonists activate both G-protein and beta-arrestin-2 pathways — the latter being associated with receptor desensitization, tolerance, and adverse respiratory effects — SR-17018 preferentially engages G-protein signaling. This functional selectivity makes it an ideal pharmacological probe for dissecting the molecular mechanisms underlying opioid analgesia versus side effects, and it is widely referenced in the scientific literature on biased agonism and next-generation opioid therapeutics.

How should SR-17018 be prepared and handled for in vitro opioid receptor assays?

SR-17018 is typically prepared as a stock solution in DMSO at a concentration of 10 mM, then diluted into aqueous assay buffer to the desired working concentration. It is important to ensure that the final DMSO concentration in assay media does not exceed 0.1% to avoid cytotoxicity or receptor interference. All handling should be performed under appropriate laboratory safety conditions; consult the provided SDS for full PPE and disposal guidance. Store unused stock solutions at -20°C in tightly sealed aliquots to prevent degradation and freeze-thaw cycling.

Where can I buy SR-17018 online at the best price with guaranteed purity?

You can order SR-17018 online directly from Cayman Chemical Company, a globally recognized supplier of high-purity research chemicals for the life sciences. Cayman offers SR-17018 for sale with full analytical certification, competitive best-price guarantees, and reliable international shipping. Our quality assurance processes — including independent HPLC verification and lot-specific CoA documentation — ensure that every milligram you receive meets the stringent standards required for peer-reviewed research. Shop SR-17018 today and benefit from our responsive technical support team, who can assist with compound selection, formulation advice, and assay optimization.

Ready to advance your opioid receptor research? Shop SR-17018 at Cayman Chemical Company today and experience the quality, transparency, and scientific rigor that thousands of researchers worldwide rely on. Whether you need a single vial for a pilot study or bulk quantities for an extended research program, we offer flexible ordering options and fast dispatch. Explore Cychlorphine and other orphine-class compounds to build a comprehensive opioid pharmacology toolkit. Add SR-17018 to your cart now and take the next step in understanding biased opioid receptor signaling.